A novel cell cycle-associated lncRNA, HOXA11-AS, is transcribed from the 5-prime end of the HOXA transcript and is a biomarker of progression in glioma

Cancer Letters

Volumn 373, Issue 2, 2016, Pages 251-259

  Wang, Qixue ^a,b,c,d   Zhang, Junxia ^d,e   Liu, Yanwei ^d,f   Zhang, Wei ^d,f   Zhou, Junhu ^a,b,c,d   Duan, Ran ^d,f   Pu, Peiyu ^a,b,c,d   Kang, Chunsheng ^a,b,c,d   Han, Lei ^a,b,c,d  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b Tianjin Neurological Institute   (China)

^c BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^d Chinese Glioma Cooperative Group (CGCG)   (China)

^e THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^f CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Cell cycle; Glioma; HOXA cluster; HOXA11 AS; Long noncoding RNAs

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN E; ISOCITRATE DEHYDROGENASE 1; LONG UNTRANSLATED RNA; PROTEIN P16; PROTEIN P21; PROTEIN P27; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HOXA11 AS; TUMOR MARKER; UNCLASSIFIED DRUG; UNTRANSLATED RNA; HOMEODOMAIN PROTEIN; HOXA11 PROTEIN, HUMAN;

ADULT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CARCINOGENESIS; CANCER GRADING; CANCER GROWTH; CANCER SURVIVAL; CARCINOGENESIS; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; GLIOBLASTOMA; GLIOMA; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TUMOR GROWTH; WESTERN BLOTTING; AGED; ANIMAL; BRAIN NEOPLASMS; DISEASE COURSE; FEMALE; GENETICS; MALE; MIDDLE AGED; MORTALITY; PHYSIOLOGY; TUMOR CELL LINE;

ADULT; AGED; ANIMALS; BIOMARKERS, TUMOR; BRAIN NEOPLASMS; CELL LINE, TUMOR; DISEASE PROGRESSION; FEMALE; GLIOMA; HOMEODOMAIN PROTEINS; HUMANS; MALE; MICE; MIDDLE AGED; PROGNOSIS; RNA, LONG NONCODING;

EID: 84958673040     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2016.01.039     Document Type: Article

References (44)

1. Venkatesh T., Suresh P.S., Tsutsumi R. Non-coding RNAs: functions and applications in endocrine-related cancer. Mol. Cell. Endocrinol 2015, 416:88-96.
2. Yan W., Liu Y., Yang P., Wang Z., You Y., Jiang T. MicroRNA profiling of Chinese primary glioblastoma reveals a temozolomide-chemoresistant subtype. Oncotarget 2015, 6(13):11676-11682.
3. Yan W., Li R., Liu Y., Yang P., Wang Z., Zhang C., et al. MicroRNA expression patterns in the malignant progression of gliomas and a 5-microRNA signature for prognosis. Oncotarget 2014, 5(24):12908-12915.
4. Ma M.Z., Chu B.F., Zhang Y., Weng M.Z., Qin Y.Y., Gong W., et al. Long non-coding RNA CCAT1 promotes gallbladder cancer development via negative modulation of miRNA-218-5p. Cell Death Dis 2015, 6:e1583.
5. Gummalla M., Galetti S., Maeda R.K., Karch F. Hox gene regulation in the central nervous system of Drosophila. Front. Cell. Neurosci 2014, 8:96.
6. Fenoglio C., Ridolfi E., Galimberti D., Scarpini E. An emerging role for long non-coding RNA dysregulation in neurological disorders. Int. J. Mol. Sci 2013, 14(10):20427-20442.
7. Wang J., Song Y.X., Wang Z.N. Non-coding RNAs in gastric cancer. Gene 2015, 560(1):1-8.
8. Fang X.Y., Pan H.F., Leng R.X., Ye D.Q. Long noncoding RNAs: novel insights into gastric cancer. Cancer Lett 2015, 356(Pt B):357-366.
9. Ren Y., Zhou X., Yang J.J., Liu X., Zhao X.H., Wang Q.X., et al. AC1MMYR2 impairs high dose paclitaxel-induced tumor metastasis by targeting miR-21/CDK5 axis. Cancer Lett 2015, 362(2):174-182.
10. Spitale R.C., Tsai M.C., Chang H.Y. RNA templating the epigenome: long noncoding RNAs as molecular scaffolds. Epigenetics 2011, 6(5):539-543.
11. Li J., Drubay D., Michiels S., Gautheret D. Mining the coding and non-coding genome for cancer drivers. Cancer Lett 2015, 369(2):307-315.
12. Yang X., Xie X., Xiao Y.F., Xie R., Hu C.J., Tang B., et al. The emergence of long non-coding RNAs in the tumorigenesis of hepatocellular carcinoma. Cancer Lett 2015, 360(2):119-124.
13. Ma K.X., Wang H.J., Li X.R., Li T., Su G., Yang P., et al. Long noncoding RNA MALAT1 associates with the malignant status and poor prognosis in glioma. Tumour Biol 2015, 36(5):3355-3359.
14. Zhou X., Ren Y., Zhang J., Zhang C., Zhang K., Han L., et al. HOTAIR is a therapeutic target in glioblastoma. Oncotarget 2015, 6(10):8353-8365.
15. Nie F.Q., Sun M., Yang J.S., Xie M., Xu T.P., Xia R., et al. Long noncoding RNA ANRIL promotes non-small cell lung cancer cell proliferation and inhibits apoptosis by silencing KLF2 and P21 expression. Mol. Cancer Ther 2015, 14(1):268-277.
16. Hung C.L., Wang L.Y., Yu Y.L., Chen H.W., Srivastava S., Petrovics G., et al. A long noncoding RNA connects c-Myc to tumor metabolism. Proc. Natl. Acad. Sci. U.S.A. 2014, 111(52):18697-18702.
17. Wang X., Wang K., Han L., Zhang A., Shi Z., Zhang K., et al. PRDM1 is directly targeted by miR-30a-5p and modulates the Wnt/β-catenin pathway in a Dkk1-dependent manner during glioma growth. Cancer Lett 2013, 331(2):211-219.
18. Zhang K.L., Han L., Chen L.Y., Shi Z.D., Yang M., Ren Y., et al. Blockage of a miR-21/EGFR regulatory feedback loop augments anti-EGFR therapy in glioblastomas. Cancer Lett 2014, 342(1):139-149.
19. Wang Y., Wang Y., Li J., Zhang Y., Yin H., Han B. CRNDE, a long-noncoding RNA, promotes glioma cell growth and invasion through mTOR signaling. Cancer Lett 2015, 367(2):122-128.
20. Yao Y., Ma J., Xue Y., Wang P., Li Z., Liu J., et al. Knockdown of long non-coding RNA XIST exerts tumor-suppressive functions in human glioblastoma stem cells by up-regulating miR-152. Cancer Lett 2015, 359(1):75-86.
21. Bao Z., Zhang C., Yan W., Liu Y., Li M., Zhang W., et al. BMP4, a strong better prognosis predictor, has a subtype preference and cell development association in gliomas. J. Transl. Med 2013, 11:100.
22. Bao Z.S., Li M.Y., Wang J.Y., Zhang C.B., Wang H.J., Yan W., et al. Prognostic value of a nine-gene signature in glioma patients based on mRNA expression profiling. CNS Neurosci. Ther 2014, 20(2):112-118.
23. Duan R., Han L., Wang Q., Wei J., Chen L., Zhang J., et al. HOXA13 is a potential GBM diagnostic marker and promotes glioma invasion by activating the Wnt and TGF-β pathways. Oncotarget 2015, 6(29):27778-27793.
24. Zheng Q., Han L., Dong Y., Tian J., Huang W., Liu Z., et al. JAK2/STAT3 targeted therapy suppresses tumor invasion via disruption of the EGFRvIII/JAK2/STAT3 axis and associated focal adhesion in EGFRvIII-expressing glioblastoma. Neuro Oncol 2014, 16(9):1229-1243.
25. Chen L., Zhang A., Li Y., Zhang K., Han L., Du W., et al. MiR-24 regulates the proliferation and invasion of glioma by ST7L via β-catenin/Tcf-signaling. Cancer Lett 2013, 329(2):174-180.
26. Shi Z., Zhang J., Qian X., Han L., Zhang K., Chen L., et al. AC1MMYR2, an inhibitor of dicer-mediated biogenesis of Oncomir miR-21, reverses epithelial-mesenchymal transition and suppresses tumor growth and progression. Cancer Res 2013, 73(17):5519-5531.
27. Zhang J., Chen L., Han L., Shi Z., Zhang J., Pu P., et al. EZH2 is a negative prognostic factor and exhibits pro-oncogenic activity in glioblastoma. Cancer Lett 2015, 356(Pt B):929-936.
28. Chen L., Han L., Wei J., Zhang K., Shi Z., Duan R., et al. SNORD76, a box C/D snoRNA, acts as a tumor suppressor in glioblastoma. Sci. Rep 2015, 5:8588.
29. Han L., Zhang K.L., Zhang J.X., Zeng L., Di C.H., Fee B.E., et al. AJAP1 is dysregulated at an early stage of gliomagenesis and suppresses invasion through cytoskeleton reorganization. CNS Neurosci. Ther 2014, 20(5):429-437.
30. Zhou X., Ren Y., Moore L., Mei M., You Y., Xu P., et al. Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status. Lab. Invest 2010, 90(2):144-155.
31. Zhang C., Kang C., You Y., Pu P., Yang W., Zhao P., et al. Co-suppression of miR-221/222 cluster suppresses human glioma cell growth by targeting p27kip1 in vitro and in vivo. Int. J. Oncol 2009, 34(6):1653-1660.
32. Verhaak R.G., Hoadley K.A., Purdom E., Wang V., Qi Y., Wilkerson M.D., et al. Cancer Genome Atlas Research Network. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 2010, 17(1):98-110.
33. Wang Y., Wu K., Yang Z., Zhao Q., Fan D., Xu P., et al. Multidrug-resistance related long non-coding RNA expression profile analysis of gastric cancer. PLoS ONE 2015, 10(8):e0135461.
34. Sun Q.L., Zhao C.P., Wang T.Y., Hao X.B., Wang X.Y., Zhang X., et al. Expression profile analysis of long non-coding RNA associated with vincristine resistance in colon cancer cells by next-generation sequencing. Gene 2015, 572(1):79-86.
35. Rinn J.L., Kertesz M., Wang J.K., Squazzo S.L., Xu X., Brugmann S.A., et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 2007, 129(7):1311-1323.
36. Ferguson L., Marlétaz F., Carter J.M., Taylor W.R., Gibbs M., Breuker C.J., et al. Ancient expansion of the hox cluster in lepidoptera generated four homeobox genes implicated in extra-embryonic tissue formation. PLoS Genet 2014, 10(10):e1004698.
37. Richards E.J., Zhang G., Li Z.P., Permuth-Wey J., Challa S., Li Y., et al. Long non-coding RNAs (LncRNA) regulated by transforming growth factor (TGF) β: lncRNA-hit-mediated TGFβ-induced epithelial to mesenchymal transition in mammary epithelia. J. Biol. Chem 2015, 290(11):6857-6867.
38. Gupta R.A., Shah N., Wang K.C., Kim J., Horlings H.M., Wong D.J., et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010, 464(7291):1071-1076.
39. Tsai M.C., Manor O., Wan Y., Mosammaparast N., Wang J.K., Lan F., et al. Long noncoding RNA as modular scaffold of histone modification complexes. Science 2010, 329(5992):689-693.
40. Tsang F.H., Au S.L., Wei L., Fan D.N., Lee J.M., Wong C.C., et al. Long non-coding RNA HOTTIP is frequently up-regulated in hepatocellular carcinoma and is targeted by tumour suppressive miR-125b. Liver Int 2015, 35(5):1597-1606.
41. Li Z., Zhao X., Zhou Y., Liu Y., Zhou Q., Ye H., et al. The long non-coding RNA HOTTIP promotes progression and gemcitabine resistance by regulating HOXA13 in pancreatic cancer. J. Transl. Med 2015, 13:84.
42. Zhang H., Zhao L., Wang Y.X., Xi M., Liu S.L., Luo L.L. Long non-coding RNA HOTTIP is correlated with progression and prognosis in tongue squamous cell carcinoma. Tumour Biol 2015, 36(11):8805-8809.
43. Richards E.J., Permuth-Wey J., Li Y., Chen Y.A., Coppola D., Reid B.M., et al. A functional variant in HOXA11-AS, a novel long non-coding RNA, inhibits the oncogenic phenotype of epithelial ovarian cancer. A functional variant in HOXA11-AS, a novel long non-coding RNA, inhibits the oncogenic phenotype of epithelial ovarian cancer. Oncotarget 2015, 6(33):34745-34757.
44. Zhang K., Sun X., Zhou X., Han L., Chen L., Shi Z., et al. Long non-coding RNA HOTAIR promotes glioblastoma cell cycle progression in an EZH2 dependent manner. Oncotarget 2015, 6(1):537-546.